Suppr超能文献

复发性症状性颅内重度狭窄:小号支架的安全性和有效性——初步经验

Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents--initial experience.

作者信息

de Rochemont Richard du Mesnil, Turowski Bernd, Buchkremer Martin, Sitzer Matthias, Zanella Friedhelm E, Berkefeld Joachim

机构信息

Institute of Neuroradiology and Department of Neurology, Johann Wolfgang Goethe-University Frankfurt, Schleusenweg 2-16, 60528 Frankfurt, Germany.

出版信息

Radiology. 2004 Apr;231(1):45-9. doi: 10.1148/radiol.2311030183.

Abstract

PURPOSE

To prospectively evaluate the safety and efficacy of undersized stents used in patients with high-grade intracranial stenosis and recurrent ischemic symptoms who are undergoing medical treatment.

MATERIALS AND METHODS

In 18 patients (13 men, five women; age range, 51-82 years), 20 high-grade (>70%) intracranial stenoses were selected for stent placement. All patients had transient ischemic symptoms or minor strokes while undergoing combined antithrombotic therapy with acetylsalicylic acid plus clopidogrel or anticoagulation therapy with warfarin or heparin plus acetylsalicylic acid. Technical success was defined as reaching the target lesion and deploying a stent, with a residual stenosis of less than 50%. The diameter of the stent was 0.5-mm smaller than the measured diameter of the normal adjacent vessel to avoid dissection and vessel rupture. Primary endpoints for safety evaluation were the combined incidence of death or major or minor stroke at 30 days; for efficacy evaluation, the primary endpoint was the incidence of any stroke in the treated vascular territory within the first 6 months. Statistical evaluation of the reduction of stenosis was performed.

RESULTS

In 18 of 20 stenoses, a stent was placed and the degree of stenosis was reduced from a median of 82% (range, 72%-97%) to a median of 16% (5%-40%; P <.001). The technical success rate was 90%. One patient had a parenchymal hemorrhage in a preexisting infarct on the 2nd day. Thus, the 30-day combined stroke and death rate was 6%. No immediate complication, thromboembolism, dissection compromising blood flow, or vessel rupture occurred during these procedures. Within the first 6 months after intervention, no patient had new ischemic symptoms in the treated vascular territory.

CONCLUSION

In selected patients with recurrent ischemic events due to high-grade intracranial stenosis, undersized stent placement holds promise as an effective and safe procedure.

摘要

目的

前瞻性评估尺寸较小的支架用于接受药物治疗的颅内重度狭窄且有复发性缺血症状患者的安全性和有效性。

材料与方法

选取18例患者(13例男性,5例女性;年龄范围51 - 82岁),对20处颅内重度(>70%)狭窄病变进行支架置入。所有患者在接受阿司匹林加氯吡格雷联合抗栓治疗或华法林或肝素加阿司匹林抗凝治疗时均有短暂性缺血症状或轻度卒中。技术成功定义为到达靶病变并置入支架,残余狭窄小于50%。支架直径比相邻正常血管测量直径小0.5 mm,以避免夹层形成和血管破裂。安全性评估的主要终点是30天时死亡、重大或轻微卒中的联合发生率;有效性评估的主要终点是治疗后血管区域在最初6个月内发生任何卒中的发生率。对狭窄程度的降低进行了统计学评估。

结果

20处狭窄病变中有18处成功置入支架,狭窄程度从中位数82%(范围72% - 97%)降至中位数16%(5% - 40%;P <.001)。技术成功率为90%。1例患者在第2天出现原有梗死灶内的脑实质出血。因此,30天时卒中与死亡率为6%。这些操作过程中未发生即刻并发症、血栓栓塞、影响血流的夹层形成或血管破裂。在干预后的前6个月内,治疗血管区域无患者出现新的缺血症状。

结论

对于因颅内重度狭窄导致复发性缺血事件的特定患者,置入尺寸较小的支架有望成为一种有效且安全的治疗方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验